Autoantibodies to contact proteins in patients with recurrent pregnancy losses

Journal of Reproductive Immunology

Volumn 53, Issue 1-2, 2002, Pages 269-277

  Sugi, Toshitaka ^a   Makino, Tsunehisa ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiphospholipid antibodies; Factor XII; Kallikrein kinin system; Kininogen; Phosphatidylethanolamine; Pregnancy loss

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 12; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; KININ; PHOSPHOLIPID ANTIBODY; PREKALLIKREIN;

ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD CLOTTING TIME; ENDOTHELIUM CELL; FETOPLACENTAL UNIT; FETUS WASTAGE; HUMAN; KALLIKREIN KININ SYSTEM; NONHUMAN; PLACENTA CIRCULATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REGULATORY MECHANISM; RISK FACTOR;

ABORTION, HABITUAL; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; FACTOR XII; FACTOR XII DEFICIENCY; FEMALE; HUMANS; KALLIKREIN-KININ SYSTEM; KININOGEN, HIGH-MOLECULAR-WEIGHT; PREGNANCY; PREKALLIKREIN; RISK FACTORS;

EID: 0036271831     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(01)00088-2     Document Type: Article

References (49)

1. Quantification of rat T-kininogen using immunological methods
2. Prevalence and kininogen-dependence of antiphosphatidylethanolamine antibodies
3. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity
4. Criteria for antiphospholipid syndrome: Early pregnancy loss, fetal loss, or recurrent pregnancy loss?
5. Obstetric complications associated with the lupus anticoagulant
6. Changes in kininogens and kallikrein in the plasma, brain, and uterus during pregnancy in the rat
7. Factor XII (Hageman) deficiency in women with habitual abortion: New subpopulation of recurrent aborters?
8. Selective stimulation of tissue type plasminogen activator (t-PA) in vivo by infusion of bradykinin
9. Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes
10. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor dependent pathways
11. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions
12. Bradykinin-induced release of prostacyclin and thromboxanes from bovine pulmonary artery endothelial cells. Studies with lower homologs and calcium antagonists
13. Factor XII determinations in the presence and absence of phospholipid antibodies
14. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII)
15. Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages
16. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss
17. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism
18. The prevalence of moderate and severe factor XII (Hageman factor) deficiency among the normal population: Evaluation of the incidence of factor XII deficiency among 300 healthy blood donors
19. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta
20. Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein
21. Kininogen present in rat reproductive tissues is apparently synthesized by the liver, not by the reproductive system
22. Evidence for a role of factor XII-dependent fibrinolysis in cardiobascular diseases
23. Antibodies to FXII associated with lupus anticoagulant
24. The intrinsic coagulation/kinin-forming cascade: Assembly in plasma and cell surfaces in inflammation
25. Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis
26. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus
27. 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women
28. Thromboembolism and bleeding tendency in congenital factor XII deficiency-A study on 74 subjects from 14 swiss families
29. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence of the role of the contact system in fibrinolysis in vivo
30. Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis
31. Phospholipid binding plasma proteins required for antiphospholipid antibody detection-an overview
32. Anti-phosphatidylethanolamine (aPE) antibodies: A survey
33. Biochemical evidence for a kallikrein-like activity in rat reproductive tissue
34. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: A novel mechanism for contact activation
35. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium
36. Nitric Oxide release accounts for the biologic activity of endothelium-delived relaxing factor
37. Pathogenesis and treatment of the antiphospholipid antibody syndrome
38. Fitzgerald trait: Deficiency of a hitherto unrecognized agent, fitzgerald factor, participating in surface mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF/DIL)
39. Factor XII congenital deficiency and early spontaneous abortion
40. Autoactivation of human Hageman factor: Demonstration utilizing a synthetic substrate
41. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis
42. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex
43. Plasma proteins required for antiphospholipid antibody detection
44. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies
45. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses
46. Kinetics of activation and autoactivation of human factor XII
47. Autoantibodies to factor XII in patients with recurrent pregnancy losses
48. The presence of glandular kallikrein in rabbit fetal placental conditioned medium
49. Flaujeac trait. Deficiency of human plasma kininogen